title: Multiple clinical vertebral fractures following denosumab discontinuation.
authors.affiliation: Department of Endocrinology, 424 General Military Hospital, Ring Road, 564 29 N.Efkarpia, Thessaloniki, Greece. anastath@endo.gr.
authors.forename: A D
authors.initials: AD
authors.lastname: Anastasilakis
authors.affiliation: Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.
authors.forename: P
authors.initials: P
authors.lastname: Makras
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D000069448:Denosumab; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D053245:RANK Ligand; D016103:Spinal Fractures / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D053245:RANK Ligand; D000069448:Denosumab